Answers are grounded in this paper and cite their sources.
In this work, we investigated the interaction between different molecular-coated magnetite-based nanoparticles stabilized as biocompatible magnetic fluids (BMFs) and both serum albumin proteins (HSA and BSA). The investigation was focused on the fluorescence quenching of the tryptophan residue proteins after their binding with the molecular-coated magnetic nanoparticles (MNPs) at specific sites. The results showed distinct association of the BMFs with HSA and BSA, a fact that directly affects the application, biodistribution, and clinical trial therapy using colloidal stabilized MNPs.
No takes yet. Share an insight, caveat, or question.
Macaroff et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: